Stroke, Acute — Evaluating the Practice Resource for Driving After Stroke
Citation(s)
Bandura, A (1997). Self efficacy: The exercise of control. Freeman.
Barton, E E., Lloyd, B. P., Spriggs, A. D., & Gast, D. L. (2018). Visual analysis of graphic data. In J. R. Ledford & D. L. Gast (Eds.), Single Case Research Methodology: Applications in Special Education and Behavioral Sciences (3rd ed., pp. 179-214). https://doi.org/10.4324/9780203521892
Cammarata, M , Mueller, A. S., Harris, J., & Vrkljan, B. (2017). The Role of the Occupational Therapist in Driver Rehabilitation After Stroke. Physical and Occupational Therapy in Geriatrics, 35(1), 20-33. https://doi.org/10.1080/02703181.2016.1277443
Canadian Council of Motor Transport Administrators (2020). Determining Driver Fitness in Canada: Part 1 A Model for the Administration of Driver Fitness Programs and Part 2: CCMTA Medical Standards for Drivers. https://ccmta.ca/ images/CCMTAMedicalStandardsDec12015finalcleancopyJune20016 edit.bookmarkspdf.pdf
Fingerhut, J , Xu, X., & Moeyaert, M. (2021). Selecting the proper Tau-U measure for single-case experimental designs: Development and application of a decision flowchart. Evidence-Based Communication Assessment and Intervention, 15(3), 99-114. https://doi.org/10.1080/17489539.2021.1937851
Korner-Bitensky N, Menon A, von Zweck C, Van Benthem K Occupational therapists' capacity-building needs related to older driver screening, assessment, and intervention: a Canadawide survey. Am J Occup Ther. 2010 Mar-Apr;64(2):316-24. doi: 10.5014/ajot.64.2.316.
Ledford, J R., & Gast, D. L. (2018). Single Case Research Methodology: Applications in Special Education and Behavioural Sciences. Routledge.
Liddle, J , Turpin, M., McKenna, K., Kubus, T., Lambley, S., & McCaffrey, K. (2009). The experiences and needs of people who cease driving after stroke. Brain Impairment, 10(3), 271-281. https://doi.org/10.1375/brim.10.3.271
Murray A, Di Tommaso A, Molineux M, Young A, Power P Contemporary occupational therapy philosophy and practice in hospital settings. Scand J Occup Ther. 2021 Apr;28(3):213-224. doi: 10.1080/11038128.2020.1750691. Epub 2020 May 1.
O'Brien, K M., Kearney, M. S., & Sauber, E. (2019). Measuring career and occupational self-efficacy. In M. W. Gallagher & S. J. Lopez (Eds.), Positive psychological assessment: A handbook of models and measures (2nd ed.). (2nd ed., pp. 97-110). American Psychological Association. https://doi.org/10.1037/0000138-007
Parker RI, Vannest KJ, Davis JL, Sauber SB Combining nonoverlap and trend for single-case research: Tau-U. Behav Ther. 2011 Jun;42(2):284-99. doi: 10.1016/j.beth.2010.08.006. Epub 2011 Feb 3.
Patomella AH, Johansson K, Tham K Lived experience of driving ability following stroke. Disabil Rehabil. 2009;31(9):726-33. doi: 10.1080/09638280802306539.
Peterson, J , McGillis Hall, L., O'Brien-Pallas, L., & Cockerill, R. (2011). Job satisfaction and intentions to leave of new nurses. Journal of Research in Nursing, 16(6), 536-548. https://doi.org/10.1177/1744987111422423
Riggs, M L., Warka, J., Babasa, B., Betancourt, R., & Hooker, S. (1994). Development and Validation of Self-Efficacy and Outcome Expectancy Scales for Job-Related Applications. Educational and Psychological Measurement, 54(3), 793-802.
Royeen, C , Mu, K., Barnett, K., & Luebbeb, A. (2000). Pilot Investigtion: Evaluation of Clinical Refelction and Reasoning. In P. A. H. Crist (Ed.), Innovations in Occupational therapy education (pp. 107-115). American Occupational Therapy Association.
Sangrar, R , Griffith, L. E., Letts, L., & Vrkljan, B. (2018). Examining Occupational Therapists' Awareness of Medical Fitness-to-Drive Legislation Using a Knowledge-to-Action Approach. Topics in Geriatric Rehabilitation, 34(4), 274-282. https://doi.org/10.1097/TGR.0000000000000205
Simmons B Clinical reasoning: concept analysis. J Adv Nurs. 2010 May;66(5):1151-8. doi: 10.1111/j.1365-2648.2010.05262.x. Epub 2010 Mar 9.
Tate (2018). Multiple-Baseline Designs. In R. Tate & M. Perdices (Eds.), Single-Case Experimental Designs for Clinical Research and Neurorehabilitation Settings (1st ed., pp. 108-130). Routledge. https://doi-org.proxy1.lib.uwo.ca/10.4324/9780429488184
Vander Veen A, Cammarata M, Renner S, Alvarez L The Clinical Usefulness of the Practice Resource for Driving after Stroke (PReDAS). Occup Ther Health Care. 2023 Jan;37(1):119-144. doi: 10.1080/07380577.2021.2018751. Epub 2021 Dec 26.
Vander Veen A, Holmes J, Tucker P, Alvarez L Addressing Driving in Acute Care: Perceived Relevance and Competence. Can J Occup Ther. 2024 Mar;91(1):88-99. doi: 10.1177/00084174231182898. Epub 2023 Jun 22.
Vander Veen A, Laliberte Rudman D Rethinking Driving Against Medical Advice: The Situated Nature of Driving After Stroke. Can J Occup Ther. 2022 Dec;89(4):406-416. doi: 10.1177/00084174221114670. Epub 2022 Jul 19.
Vannest, K J., & Ninci, J. (2015). Evaluating intervention effects in single-case research designs. Journal of Counseling and Development, 93(4), 403-411. https://doi.org/10.1002/jcad.12038
Evaluating the Practice Resource for Driving After Stroke (PReDAS): A Concurrent, Multiple Baseline Study
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
